[ 177 Lu]Lu-PSMA-617 in Patients with Progressive PSMA+ mCRPC Treated With or Without Prior Taxane-Based Chemotherapy: A Phase 2, Open-Label, Single-Arm Trial in Japan †.

Saved in:
Bibliographic Details
Title: [ 177 Lu]Lu-PSMA-617 in Patients with Progressive PSMA+ mCRPC Treated With or Without Prior Taxane-Based Chemotherapy: A Phase 2, Open-Label, Single-Arm Trial in Japan †.
Authors: Izumi, Kouji1 (AUTHOR) azuizu2003@yahoo.co.jp, Matsumoto, Ryuji2 (AUTHOR), Ito, Yusuke3 (AUTHOR), Hoshi, Seiji4 (AUTHOR), Matsubara, Nobuaki5 (AUTHOR), Yamasaki, Toshinari6 (AUTHOR), Mizowaki, Takashi7 (AUTHOR), Komaru, Atsushi8 (AUTHOR), Nomura, Satoshi9 (AUTHOR), Hattori, Toru9,10 (AUTHOR), Kambara, Hiroya9,11 (AUTHOR), Alanee, Shaheen10,12 (AUTHOR), Hosono, Makoto1,11 (AUTHOR), Kinuya, Seigo2,12 (AUTHOR)
Source: Cancers. Jul2025, Vol. 17 Issue 14, p2351. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers17142351